Evidence map›Paper›PMID 41125005›Full record

Trial reportPatient education and counseling2026

Integrating patient education on deprescribing into care delivery: Learnings from the Optimize pragmatic trial.

Elizabeth A Bayliss, Kathy S Gleason, Orla C Sheehan, Melanie L Drace, Courtney Kraus, Ruth Bedoy, America Elias Martinez, Jennifer K Sawyer, Jonathan Norton, Linda A Weffald and 5 more

Abstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in Patient education and counseling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Elizabeth A BaylissInstitute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO 80011, United States; Department of Family Medicine, University of Colorado School of Medicine, AO1, Mail Stop F496, Aurora, CO 80045, United States. Electronic address: elizabeth.bayliss@kp.org.
Kathy S GleasonInstitute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO 80011, United States.
Orla C SheehanDepartment of Geriatric Medicine, Royal College of Surgeons in Ireland, Connolly Hospital, Dublin 15, Blanchardstown D15 X40D, Ireland.
Melanie L DraceInstitute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO 80011, United States.
Courtney KrausInstitute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO 80011, United States.
Ruth BedoyInstitute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO 80011, United States.
America Elias MartinezInstitute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO 80011, United States.
Jennifer K SawyerInstitute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO 80011, United States.
Jonathan NortonDivision of Geriatrics, Department of Internal Medicine, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, 7th Floor, Baltimore, MD 21224, United States.
Linda A WeffaldDepartment of Clinical Pharmacy, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO 80011, United States.
Ariel R GreenDivision of Geriatrics, Department of Internal Medicine, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, 7th Floor, Baltimore, MD 21224, United States.
Emily ReeveFaculty of Pharmacy and Pharmaceutical Sciences, Centre for Medicine Use and Safety, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
Lisa E PieperInstitute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO 80011, United States.
Mahesh MaiyaniInstitute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO 80011, United States.
Cynthia M BoydDivision of Geriatrics, Department of Internal Medicine, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, 7th Floor, Baltimore, MD 21224, United States.

Funding

The U.S. Deprescribing Research NetworkR33AG086944 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI CYNTHIA Melinda BOYD, MICHAEL A. STEINMAN · 2024 to 2026
$2.5M
Optimal Medication Management in Alzheimer's Disease and DementiaR33AG057289 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI BAYLISS, ELIZABETH A, BOYD, CYNTHIA MELINDA · 2019 to 2021
$2.2M
NIA NIH HHS R33 AG057289NIA NIH HHS R33 AG086944
6 · The paper itself

Abstract

objectiveDeprescribing is not well integrated into clinical practice and improving patient education is recommended to foster deprescribing communication. Based on our experience developing, adapting, and implementing the Optimize deprescribing educational intervention for persons living with dementia, we discuss lessons learned in providing deprescribing education to patients and family members or other care partners.

methodsThe Optimize study was a cluster randomized, pragmatic trial in primary care that provided deprescribing education to individuals with cognitive impairment, polypharmacy and multiple chronic conditions, and their care partners. The initial intervention provided materials by mail ahead of visits. The delayed control intervention provided materials at the point of care. In 28 semi-structured interviews with 16 patients alone, 10 patient-caregiver dyads, and 2 caregivers alone, conducted across both intervention arms and analyzed using the framework method for implementation assessment, participants reflected on approaches to providing educational materials to support deprescribing in primary care.

resultsPatients and care partners welcomed receiving educational materials about deprescribing. Patients and care partners had varying suggestions for modes of materials delivery (e.g., online, mail, with prescriptions). Competing demands at the point of care interfered with clinic staff distributing materials at that time, although some patients were theoretically agreeable to this approach. Providers requested timing materials delivery to align with clinical encounters that foster discussing medications and goals of care.

conclusionsThese pragmatic learnings suggest that operational approaches to deprescribing education for polypharmacy include multiple team members and multiple modes of delivering information about deprescribing and polypharmacy to patients and care partners. Detailed approaches deserve further investigation.

Indexed as

CaregiversDelivery of Health CareDementiaDeprescriptionsPatient Education as TopicAgedAged, 80 and overCommunicationFemaleHumansInterviews as TopicMaleMiddle AgedPolypharmacyPrimary Health CareQualitative ResearchDeprescribingPolypharmacyPrimary care

Identifiers

PMID41125005
PMCPMC12668281

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.